82_FR_43200 82 FR 43024 - National Center for Health Statistics (NCHS), ICD-10 Coordination and Maintenance (C&M) Committee Meeting

82 FR 43024 - National Center for Health Statistics (NCHS), ICD-10 Coordination and Maintenance (C&M) Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 176 (September 13, 2017)

Page Range43024-43025
FR Document2017-19444

The Centers for Disease Control and Prevention, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD-10 Coordination and Maintenance (C&M) Committee meeting. This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. We will be broadcasting the meeting live via Webcast at http://www.cms.gov/live/.

Federal Register, Volume 82 Issue 176 (Wednesday, September 13, 2017) 
[Federal Register Volume 82, Number 176 (Wednesday, September 13, 2017)]
[Notices]
[Pages 43024-43025]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19444]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics (NCHS), ICD-10 Coordination 
and Maintenance (C&M) Committee Meeting

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention, National 
Center for Health Statistics (NCHS), Classifications and Public Health 
Data Standards Staff, announces the following meeting of the ICD-10 
Coordination and Maintenance (C&M) Committee meeting. This meeting is 
open to the public, limited only by the space available. The meeting 
room accommodates approximately 240 people. We will be broadcasting the 
meeting live via Webcast at http://www.cms.gov/live/.

DATES: The meeting will be held on September 12, 2017, 8:00 a.m. to 
5:00 p.m. EDT and September 13, 2017, 8:00 a.m. to 5:00 p.m. EDT.

ADDRESSES: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244.

FOR FURTHER INFORMATION CONTACT: Traci Ramirez, CCA, Program 
Specialist, CDC, National Center for Health Statistics (NCHS), 
Classifications and Public Health Data Standards Staff (CPHDSS), 3311 
Toledo Rd., Hyattsville, Maryland 20715, telephone (301) 458-4454, 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is 
a public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Tenth Revision, Clinical 
Modification and ICD-10 Procedure Coding System.
    Matters To Be Considered: The agenda will include discussions on.

ICD-10-PCS Topics

Irreversible Electroporation (IRE)
Shunt Ligation/Occlusion
Spinal Fusion with Interbody Fusion Device
Bypass Descending Thoracic Aorta to Abdominal Artery

ICD-10-CM Diagnosis Topics

Anemia due to Myelosuppressive Antineoplastic Chemotherapy
Cyclic Vomiting
Ecstasy Classification
Elevated Lipoprotein(a)
Factitious Disorder
Incontinence-Associated Dermatitis (IAD)
Intracranial Hypotension
Muscular Dystrophy
Neonatal Metabolic Disturbances
Other Doubling of Uterus
Primary Sclerosing Cholangitis
Tarlov Perineural Cysts
Williams Syndrome
Zika related newborn conditions

ICD-10-CM Addendum

    Agenda items are subject to change as priorities dictate.
    Security Considerations: Due to increased security requirements CMS 
has instituted stringent procedures for entrance into the building by 
non-government employees. Attendees will need to present valid 
government-issued picture identification, and sign-in at the security 
desk upon entering the building. Attendees who wish to attend the 
September 12-13, 2017, ICD-10-CM C&M meeting must submit their name and 
organization by September 8, 2017, for inclusion on the visitor list. 
This visitor list will be maintained at the front desk of the CMS 
building and used by the guards to admit visitors to the meeting.
    Participants who attended previous Coordination and Maintenance 
meetings will no longer be automatically added to the visitor list. You 
must request inclusion of your name prior to each meeting you wish 
attend.
    Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/.
    Please contact Mady Hue (410-786-4510 or [email protected]), 
for questions about the registration process.

    Note: CMS and NCHS no longer provide paper copies of handouts 
for the meeting. Electronic copies of all meeting materials will be 
posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and

[[Page 43025]]

Prevention, and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-19444 Filed 9-12-17; 8:45 am]
 BILLING CODE 4160-18-P

43024 Federal Register / Vol. 82, No. 176 / Wednesday, September 13, 2017 / Notices a final rule, advice on the scientific DEPARTMENT OF HEALTH AND Ecstasy Classification validity and quality of dose estimation HUMAN SERVICES Elevated Lipoprotein(a) and reconstruction efforts being performed for purposes of the Centers for Disease Control and Factitious Disorder compensation program, and advice on Prevention Incontinence-Associated Dermatitis petitions to add classes of workers to the (IAD) Special Exposure Cohort (SEC). In National Center for Health Statistics (NCHS), ICD–10 Coordination and Intracranial Hypotension December 2000, the President delegated responsibility for funding, staffing, and Maintenance (C&M) Committee Muscular Dystrophy operating the Advisory Board to HHS, Meeting Neonatal Metabolic Disturbances which subsequently delegated this AGENCY: Centers for Disease Control and Other Doubling of Uterus authority to the CDC. NIOSH Prevention (CDC), Department of Health implements this responsibility for CDC. Primary Sclerosing Cholangitis and Human Services (HHS). The charter was issued on August 3, Tarlov Perineural Cysts ACTION: Notice of meeting. 2001, renewed at appropriate intervals, Williams Syndrome rechartered on March 22, 2016 pursuant SUMMARY: The Centers for Disease Zika related newborn conditions to Executive Order 13708, and will Control and Prevention, National Center expire on September 30, 2017. for Health Statistics (NCHS), ICD–10–CM Addendum Purpose: This Advisory Board is Classifications and Public Health Data charged with (a) providing advice to the Standards Staff, announces the Agenda items are subject to change as Secretary, HHS, on the development of following meeting of the ICD–10 priorities dictate. guidelines under Executive Order Coordination and Maintenance (C&M) Security Considerations: Due to 13179; (b) providing advice to the Committee meeting. This meeting is increased security requirements CMS Secretary, HHS, on the scientific open to the public, limited only by the has instituted stringent procedures for validity and quality of dose space available. The meeting room entrance into the building by non- reconstruction efforts performed for this accommodates approximately 240 government employees. Attendees will program; and (c) upon request by the people. We will be broadcasting the need to present valid government-issued Secretary, HHS, advising the Secretary meeting live via Webcast at http:// picture identification, and sign-in at the on whether there is a class of employees www.cms.gov/live/. security desk upon entering the at any Department of Energy facility DATES: The meeting will be held on building. Attendees who wish to attend who were exposed to radiation but for September 12, 2017, 8:00 a.m. to 5:00 the September 12–13, 2017, ICD–10–CM whom it is not feasible to estimate their p.m. EDT and September 13, 2017, 8:00 C&M meeting must submit their name radiation dose, and on whether there is a.m. to 5:00 p.m. EDT. and organization by September 8, 2017, reasonable likelihood that such ADDRESSES: Centers for Medicare and for inclusion on the visitor list. This radiation doses may have endangered Medicaid Services (CMS) Auditorium, visitor list will be maintained at the the health of members of this class. 7500 Security Boulevard, Baltimore, front desk of the CMS building and used Matters To Be Considered: The agenda Maryland 21244. by the guards to admit visitors to the will include discussions on: Final Vote FOR FURTHER INFORMATION CONTACT: meeting. Counts from the August ABRWH Traci Ramirez, CCA, Program Specialist, Participants who attended previous Meeting for Feeds Material Production CDC, National Center for Health Coordination and Maintenance meetings Center SEC petition (Fernald, OH), Statistics (NCHS), Classifications and will no longer be automatically added to Idaho National Laboratory SEC petition Public Health Data Standards Staff the visitor list. You must request (Scoville, ID), and Grand Junction (CPHDSS), 3311 Toledo Rd., Hyattsville, inclusion of your name prior to each Facilities SEC petition (Grand Junction, Maryland 20715, telephone (301) 458– meeting you wish attend. CO); Savannah River Site SEC Petition 4454, tfr4@cdc.gov. Please register to attend the meeting (Aiken, SC); Work Group and SUPPLEMENTARY INFORMATION: on-line at: http://www.cms.hhs.gov/ Subcommittee Reports; Update on the Purpose: The ICD–10 Coordination apps/events/. Status of SEC Petitions; Plans for the and Maintenance (C&M) Committee is a December 2017 Advisory Board public forum for the presentation of Please contact Mady Hue (410–786– Meeting; and Advisory Board proposed modifications to the 4510 or Marilu.hue@cms.hhs.gov), for Correspondence. Agenda items are International Classification of Diseases, questions about the registration process. subject to change as priorities dictate. Tenth Revision, Clinical Modification Note: CMS and NCHS no longer provide The Director, Management Analysis and ICD–10 Procedure Coding System. paper copies of handouts for the meeting. and Services Office, has been delegated Matters To Be Considered: The agenda Electronic copies of all meeting materials the authority to sign Federal Register will include discussions on. will be posted on the CMS and NCHS Web notices pertaining to announcements of sites prior to the meeting at http:// ICD–10–PCS Topics meetings and other committee www.cms.hhs.gov/ICD9ProviderDiagnostic management activities, for both the Irreversible Electroporation (IRE) Codes/03_meetings.asp#TopOfPage and Centers for Disease Control and Shunt Ligation/Occlusion https://www.cdc.gov/nchs/icd/icd10cm_ Prevention and the Agency for Toxic Spinal Fusion with Interbody Fusion maintenance.htm. sradovich on DSK3GMQ082PROD with NOTICES Substances and Disease Registry. Device Bypass Descending Thoracic Aorta to The Director, Management Analysis Claudette Grant, Abdominal Artery and Services Office, has been delegated Acting Director, Management Analysis and the authority to sign Federal Register Services Office, Centers for Disease Control ICD–10–CM Diagnosis Topics notices pertaining to announcements of and Prevention. Anemia due to Myelosuppressive meetings and other committee [FR Doc. 2017–19443 Filed 9–12–17; 8:45 am] Antineoplastic Chemotherapy management activities, for both the BILLING CODE 4163–19–P Cyclic Vomiting Centers for Disease Control and VerDate Sep<11>2014 17:34 Sep 12, 2017 Jkt 241001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\13SEN1.SGM 13SEN1

Federal Register / Vol. 82, No. 176 / Wednesday, September 13, 2017 / Notices 43025 Prevention, and the Agency for Toxic Title: Case Plan Requirement, Title to the child’s parental home, consistent Substances and Disease Registry. IV–E of the Social Security Act. with the best interest and special needs OMB No.: 0970–0428. of the child. Through these Claudette Grant, Respondents: State and Tribe title IV– requirements, States and Tribes also Acting Director, Management Analysis and B and title IV–E agencies. comply, in part, with title IV–B section Services Office, Centers for Disease Control Description: Under section 471(a)(16) 422(b) of the Act, which assures certain and Prevention. of title IV–E of the Social Security Act protections for children in foster care. [FR Doc. 2017–19444 Filed 9–12–17; 8:45 am] (the Act), to be eligible for payments, The case plan is a written document BILLING CODE 4160–18–P states and tribes must have an approved that provides a narrative description of title IV–E plan that provides for the the child-specific program of care. development of a case plan for each Federal regulations at 45 CFR 1356.21(g) DEPARTMENT OF HEALTH AND child for whom the State or Tribe and section 475(1) of the Act delineate HUMAN SERVICES receives foster care maintenance the specific information that should be payments and that provides a case addressed in the case plan. The Administration for Children and review system that meets the Administration for Children and Families requirements in section 475(5) and Families (ACF) does not specify a 475(6) of the Act. recordkeeping format for the case plan Proposed Information Collection The case review system assures that nor does ACF require submission of the Activity; Comment Request each child has a case plan designed to document to the Federal government. achieve placement in a safe setting that Case plan information is recorded in a Proposed Projects: Grant Reviewer is the least restrictive (most family-like) format developed and maintained by the Recruitment and Recordkeeping. setting available and in close proximity State or Tribal child welfare agency. ANNUAL BURDEN ESTIMATES Number of Average Number of Total burden Instrument responses per burden hours respondents hours respondent per response Case Plan ........................................................................................................ 544,098 1 4.80 2,626,436 Estimated Total Annual Burden comments and suggestions submitted study recommendations for this class of Hours: 2,626,436. within 60 days of this publication. drug given its unique characteristics. In compliance with the requirements This draft guidance is intended to Robert Sargis, of the Paperwork Reduction Act of 1995 provide recommendations for a pathway (Pub. L. 104–13, 44 U.S.C. Chap 35), the Reports Clearance Officer. to full drug development (marketing Administration for Children and [FR Doc. 2017–19367 Filed 9–12–17; 8:45 am] authorization) for microdose Families is soliciting public comment BILLING CODE 4184–25–P radiopharmaceutical diagnostic drugs. on the specific aspects of the DATES: Submit either electronic or information collection described above. written comments on the draft guidance Copies of the proposed collection of DEPARTMENT OF HEALTH AND by November 13, 2017 to ensure that the information may be obtained and HUMAN SERVICES Agency considers your comment on this comments may be forwarded by writing Food and Drug Administration draft guidance before it begins work on to the Administration for Children and the final version of the guidance. Families, Office of Planning, Research [Docket No. FDA–2017–D–5297] ADDRESSES: You may submit comments and Evaluation, 330 C Street SW., on any guidance at any time as follows: Washington, DC 20201. Attn: ACF Microdose Radiopharmaceutical Reports Clearance Officer. Email Diagnostic Drugs: Nonclinical Study Electronic Submissions address: infocollection@acf.hhs.gov. All Recommendations; Draft Guidance for Submit electronic comments in the requests should be identified by the title Industry; Availability following way: of the information collection. AGENCY: Food and Drug Administration, • Federal eRulemaking Portal: The Department specifically requests HHS. https://www.regulations.gov. Follow the comments on: (a) Whether the proposed ACTION: Notice of availability. instructions for submitting comments. collection of information is necessary Comments submitted electronically, for the proper performance of the SUMMARY: The Food and Drug including attachments, to https:// functions of the agency, including Administration (FDA or Agency) is www.regulations.gov will be posted to whether the information shall have announcing the availability of a draft the docket unchanged. Because your practical utility; (b) the accuracy of the guidance for industry entitled comment will be made public, you are agency’s estimate of the burden of the ‘‘Microdose Radiopharmaceutical solely responsible for ensuring that your proposed collection of information; (c) Diagnostic Drugs: Nonclinical Study comment does not include any the quality, utility, and clarity of the Recommendations.’’ This draft guidance confidential information that you or a sradovich on DSK3GMQ082PROD with NOTICES information to be collected; and (d) is intended to assist developers of third party may not wish to be posted, ways to minimize the burden of the microdose radiopharmaceutical such as medical information, your or collection of information on diagnostic drugs on the nonclinical anyone else’s Social Security number, or respondents, including through the use studies recommended to support human confidential business information, such of automated collection techniques or clinical trials and marketing as a manufacturing process. Please note other forms of information technology. authorization. The draft guidance that if you include your name, contact Consideration will be given to discusses how to refine nonclinical information, or other information that VerDate Sep<11>2014 17:34 Sep 12, 2017 Jkt 241001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\13SEN1.SGM 13SEN1


Document Created: 2017-09-13 00:09:21
Document Modified: 2017-09-13 00:09:21
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of meeting.
DatesThe meeting will be held on September 12, 2017, 8:00 a.m. to 5:00 p.m. EDT and September 13, 2017, 8:00 a.m. to 5:00 p.m. EDT.
ContactTraci Ramirez, CCA, Program Specialist, CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff (CPHDSS), 3311 Toledo Rd., Hyattsville, Maryland 20715, telephone (301) 458-4454, [email protected]
FR Citation82 FR 43024 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR